The mean MT-1A concentration was 214.50 ± 59.87 pg/mL in the control subjects and 238.60 ± 86.75 pg/mL in the MS patients (Figure 4A), with a slight difference between the groups (p > 0.05). Here, MT1A is linked to myeloid sarcoma.